Welcome …to a website
created so individuals might allow their imagination to soar and enhance their artwork and separate it from the humdrum of today’s mass produced frames. Enter here and find a variety of fresh ideas in hand crafted antique country style primitive and rustic frames of the highest quality created to set off your piece with that individual look we all wish to achieve. Feel free to choose from some of our ideas or contact us with yours…
Frequently Asked Questions About Our Handmade Frames
Can I order a Custom Frame size?
Of course! Please specify what size you are looking for and we will be glad to make it for you!
Do you do custom embellishments?
Yes, but we need to talk first.
‘There Is An Active Discussion Of CBD Happening Across The Country,’ Says A New Report. And That Spells Opportunity.
In 2017, when celebrity host (The View) Whoopi Goldberg was enjoying the high point of her then-new CBD brand, Maya & Whoopi, a reporter asked what the next step was. “World domination,” Goldberg joked at the time.
She might have been onto something.
Goldberg this year parted ways with her business partner, Maya Elisabeth; the result was that their company folded. But if Goldberg back in 2017 was predicting a big future for CBD startups, she wasn’t off the mark, judging from a the findings of a new survey from New Frontier Data.
“The newness of the CBD experience for most consumers suggests there remains significant opportunity for well-developed brands to attract consumer attention and capture market share from existing market leaders,” the report says. A big reason why startups might have an edge, the researchers imply? The novelty factor.
“Consumers have not been using the products with sufficient longevity to create durable brand loyalty that is difficult to dislodge,” the report says.
To compile the study, New Frontier Data surveyed 4,074 U.S. adults in mid-March. The survey population consisted of 26% of subjects who earned less than $30,000; 27% earning $39,000 to $59,999; 27% earning $60,000 to $89,999; and 16% earning $90,000 and up.
Among the report’s chief takeaways:
Familiarity with CBD is an important factor
· CBD is hardly unknown to the American mainstream. “Nearly 9 in 10 Americans are familiar with CBD,” the report says. Some 86% of those surveyed had heard of CBD, and a majority (55%) were interested in learning more. Younger cohorts tended to be more interested than older groups.
· Word of mouth is a common thread: Nearly 3 in 4 (73%) of those surveyed who’d heard of CBD reported having had a conversation about it, including the 67% who had not consumed it. People reported that their conversations were largely positive.
· Positive associations: 51% of those surveyed knew a friend or family member who’d used CBD, and nearly 1 in 5 (17%) had recommended CBD to someone else.
· Frequency: Among Americans who reported ever having consumed CBD, 40% said they did so at least once a week, with older consumers using it more frequently than younger ones.
· CBD consumers seem to be evangelists. A majority, 56%, said they had recommended CBD products to someone else.
Stress and pain are major reasons for use
· Three in five (60%) of consumers surveyed reported using CBD in a context that might be called “unwinding,” such as relaxation, relief of stress or anxiety reduction. The primary use, however (41%), was pain management.
Means of Consumption
· Oils and tinctures led the way, at 38% (of the ways in which consumers surveyed consume CBDs). Topicals were the next most widely used method, at 19%; then: food or drinks, 18%; flower, 8%; pills/capsules, 7%; and vaping, 7%.
· Some 43% of consumers said they used less than 30 mg. a day; 22% reported using 50 mg. or more; and 12% used 100 mg. or more a day.
· Some 65% of consumers surveyed said CBD had positively affected their quality of life. Only 2% described a negative effect.
Level of expenditure
· Most consumers (59%) said they spent less than $50 a month on CBD.
· Some 46% of male consumers surveyed said they used CBD at least once a week, versus 36% of women in the survey population.
· On average, men spent more for CBD than did women. Men were more likely (21%) than women (12%) to spend more than $100 per month. Purchasers ages 35 to 54 were the most likely (21%) of any group to spend more than $100 per month.
· CBD purchasers reported being generally happy with the products they were able to purchase, depending on the regulations in their geographic area; 71% agreed they were satisfied with their purchases.
· When selecting which CBD product to purchase, price and quantity of CBD were the most important factors to those surveyed. Convenience of location and service from staff were also important criteria.
· Some 51% of purchasers said they usually purchased familiar brands. About 29% said they would be likely to purchase CBD in the next six months.
Where the Opportunities Lie
For CBD startups, the women’s market for might be one smart place to focus, considering that male survey respondents were far more likely (21%) than women (12%) to spend more than $100 per month.
Another wise move might be to market only products backed by clinical studies and clear, authoritative information. The reasons here would be the importance consumers put on reliable information, as well as the strict FDA restrictions against promoting CBD for medical purposes.
Infusions as a method for consumption also seem to be of growing interest, while smoking is losing users due to social norms, especially during the current COVID-19 crisis when so many cannabis medical users are housebound.
Finally, given the anxiety during the crisis and the prevalence of word of mouth in spreading information about CBDs, companies might want to turn to such marketing channels as referral discounts, loyalty programs and high-production-value consumer testimonials, according to the New Frontier Data report.
If you follow this column and keep a close eye on the cannabidiol (CBD) market, you know that the FDA considers the sale and marketing of CBD-infused dietary supplements unlawful. Because CBD was examined and approved as a new drug ingredient– Epidiolex– prior to CBD was marketed as a dietary supplement, the sale and marketing of these items violates the FDCA.
Yet, in spite of the FDA’s position, a growing variety of CBD stakeholders have actually been arguing that the Drug Exclusion Rule does not use to their CBD products sold and marketed as dietary supplements because they contain complete- or broad-spectrum hemp extract, as opposed to CBD isolate, which is the substance that was authorized in Epidiolex.
This distinction can be linked to a 2001 court decision, Pharmanex, Inc. v. Shalala, which referred to the status of lovastatin, a compound discovered in red yeast rice. Although red yeast rice had actually been utilized for recovery purposes for thousands of years, the isolated compound was approved by the FDA as a drug active ingredient in the treatment of cholesterol.
Following the approval of lovastatin as a drug component, the FDA challenged making use of this compound in a dietary supplement and prevailed. The court held that the lovastatin found in the dietary supplement was not in its natural type because its producer deliberately picked and used a method to produce specific levels of lovastatin that were higher than those naturally present in red yeast rice. In addition, the court determined that the product offered as a dietary supplement was a drug because it was expressly marketed as the isolated lovastatin substance.
The Pharmanex case might determine how the FDA treats hemp CBD dietary supplements, particularly full- and broad-spectrum hemp extracts.
Hemp, consisting of full- and broad-spectrum hemp extracts, includes many active substances, including cannabinoids and terpenes. Hemp can be processed in a number of methods, some of which will isolate those active compounds.
Epidiolex is an example of a CBD isolate. Usually, a CBD isolate contains no other substances.
Following the thinking in the Pharmanex case, CBD isolate might be subject to the Drug Exclusion Rule, but processed hemp, such as complete- and broad-spectrum hemp extracts, may not. Hemp and full- and broad-spectrum hemp extracts are not the very same as a CBD isolate. CBD isolate or processed hemp that contains isolated and increased concentrations of CBD would be equivalent to the separated lovastatin substance in the Pharmanex case, and hence, might only be lawfully offered as drugs.
The parallels between the Pharmanex case and CBD are tough to ignore. However, while this legal argument has benefit, it is simply speculative. Undoubtedly, to my knowledge, no CBD business has actually yet produced this legal theory to challenge the FDA’s position in a law court.
Nevertheless, it is worth discussing that in its statement released shortly after the enactment of the Farming Enhancement Act of 2018 (the 2018 Farm Bill), the FDA suggested that it might consider such argument against the application of the Drug Exemption Rule to complete- and broad-spectrum hemp extracts in regulating CBD items:
[P] athways remain readily available for the FDA to consider whether there are situations in which particular cannabis-derived substances might be permitted in a food or dietary supplement. Although such items are generally restricted to be presented in interstate commerce, the FDA has authority to provide a policy enabling the usage of a pharmaceutical ingredient in a food or dietary supplement. We are taking brand-new steps to examine whether we need to pursue such a procedure. (Emphasis included).
Indeed, as the company discussed in its 2016 draft guidance for new dietary component alerts, the FDA Secretary has the authority to bypass the Drug Exclusion Rule by releasing “a regulation, after notification and remark, finding that the ingredient, when used as or in a dietary supplement, would be legal under [the FDCA].”
Additionally, the recent intro in Congress of H.R. 5587, which would excuse hemp CBD from the FDCA’s Drug Exclusion Guideline, thereby permitting the sale of hemp CBD as a dietary supplement in interstate commerce, recommends that lawmakers are not pleased with the firm’s existing treatment of hemp CBD products and support the market’s position that CBD items be regulated as dietary supplements.
Only time will tell how the FDA will ultimately regulate CBD items, however one thing appears certain: if the FDA opts to preserve a strong position and treat all CBD dietary supplements as “drugs,” then the parallels in between red yeast rice and hemp CBD will likely be litigated to settle this issue.
Nathalie Bougenies practices in the Portland workplace of Harris Bricken and was called a “2019 Rising Star” by Super Lawyers Publication, an honor bestowed on only 2.5%of qualified Oregon attorneys. Nathalie’s practice focuses on the regulatory framework of hemp-derived CBD (” hemp CBD”) products. She is an authority on FDA enforcement, Food, Drug & Cosmetic Act and other laws and policies surrounding hemp and hemp CBD products.
Love ATL? Let’s make it main.
Sign up for our newsletter.
Pot stocks are a dime a dozen these days. There is no scarcity of business out there promoting that their cannabis is higher quality than their peers. For financiers, it makes investing in a marijuana business even more hard, particularly when it pertains to finding up-and-coming stocks.
Having the ability to inform which stock is a pretender and which one is the genuine deal isn’t an easy task, however this obscure pot stock has a competitive advantage over its peers.
A biotech company that’s turned to marijuana
Amyris ( NASDAQ: AMRS) is in the business of health and health and professes to produce pure components for its customers. In March 2019, the business revealed that it signed an agreement worth possibly $300 million with Lavvan, a then-recently formed company. The companies agreed to work together in bringing cannabinoid products to market, with Amyris concentrating on the research study and advancement part of the process.
Image source: Getty Images.
In 2019, Amyris tape-recorded earnings of $183 million associated to the deal. It represented a modest 12%of the business’s overall sales for the year but it’s an amazing development opportunity for investors.
Why there could be an even larger opportunity for Amyris
The agreement that Amyris has in place with Lavvan is an attractive one, however that might simply be the start of its opportunities in the industry. In March, Amyris unveiled the outcomes of a study conducted by the Cosmos Technical. The study discovered that Amyris’ technique for delivering cannabidiol (CBD) through sugarcane squalane was more reliable than hemp seed oil and other methods of carrying CBD. It was able to permeate the skin at a much greater level. The business’s Neossance Squalane item was able to deliver 10 to 40 times more CBD to the skin compared to other oils.
A quicker and more impactful way to deliver CBD could open up lots of chances for Amyris in the CBD market. The company has said it’s used for a patent to protect its approach of delivering CBD and other cannabinoids through the use of squalane.
If the business can protect a patent on a superior technique for delivering CBD, it might be a crucial differentiator. Not just will that assist the company satisfy turning points related to its arrangement with Lavvan, but it might lead to other opportunities within the marijuana market.
Does this make Amyris a buy?
Cannabis could be what sets Amyris’ stock on fire. A patent to produce premium CBD might help the business land deals with other business in the cannabis market.
The California-based business is still in its early development stages. On May 8, Amyris launched its first-quarter outcomes which saw revenue development of 103%from the prior-year period. In 2019, its leading line grew by 140%. In spite of the difficulties and uncertainty that COVID-19 presents for the company and its consumers, Amyris still expects to see sales for 2020 to rise by 44%, with recurring sales expected to increase by 80%. The difficulty for the company stays the bottom line, where Amyris has been in the red in all but among its past 10 quarters.
Before investing in Amyris, investors need to also consider the SEC’s previous examinations into the company and Amyris’ failure to come through on pledges in the past. While the company has high expect the future, that does not suggest they’ll concern fulfillment. And till its squalane shipment technique can provide tested results, investors will be handling some risk if they purchase shares of the business.
Currently, the stock trades at a modest 2.5 times its earnings and it might be a deal buy for long-term cannabis investors Year to date, shares of Amyris are up nearly 40%while the S&P 500 is down by 6%.
Whether you’re still practicing stringent stay-at-home safety measures or carefully exploring the parts of the country that are meticulously resuming, it’s never ever been more crucial to decontaminate your hands. While it’s apparent to many that clean hands are critical during times of pandemic, Dr. Joshua Zeichner, M.D., Director of Cosmetic and Clinical Research at New York’s Mount Sinai Healthcare facility, cautions that passionate hand care is constantly important, especially when taking a trip:
” Whether there is a pandemic or not, travelers ought to constantly be additional vigilant about hand cleaning.
Sadly, as lots of are already experiencing, increased cleaning can lead to a host of skin issues, especially when the wrong products and techniques are used. As Dr. Zeichner describes, “Lots of people end up disrupting the skin barrier. When there are fractures in the outer skin layer, the skin loses hydration and ends up being inflamed.”
Happy Hands is a four-part series assembling the best items to keep your hands tidy and comfortable during the COVID-19 pandemic now, and as you take a trip back into the world after. In this edition, the 10 best cold cream and moisturizers from Many Extreme to Finest for Nature Nuts exist.
Best for Novices
Bringing CBD to the masses with accessible cost points and simple in-store access (look for it at CVS places this summer season), KARIBO CBD Instilled Hand & Body Cream is an every-day item best for the CBD-curious. With a low concentration of hemp-derived CBD (about 8.3 mg per ounce) and a cost just under $20 for a massive 12 ounces, the calming lotion is a no-risk venture into the relaxing and corrective advantages of CBD combined with the moisturizing homes of aloe vera and vitamins A and E.
Many Affordable Power
If your hands are suffering from overuse and over-washing (or you’re determined to avoid this) and you’re prepared for a more major concentration of CBD, Nourishing Body Cream from Anzie Blue uses more than 60 mg per ounce in a fast-absorbing cream at $60 for a four-ounce bottle. In addition to the therapeutic benefits of CBD leaves instilled in the cream, active ingredients like shea butter, coconut oil, mango seed butter and aloe leaf juice moisturize while chamomile and ylang further relax your skin and senses.
Finest for Pure Power
The neediest hands are going to want the greatest relief and should rely on 500 MG CBD Cold Cream from Likewise Organics, offering 250 mg per ounce of whole-plant CBD infusion in combination with vitamin C and lavender oil to soothe and recover dry and sensitive skin. Utilized by eczema and psoriasis victims, this instantaneous absorber is toxin-free and safe for the entire body, consisting of delicate facial skin. This is the high-power specialty cream to please the most unhappy hands.
Finest for Regular Use
For an undetectable barrier that keeps your skin’s natural wetness and safeguards your hands from irritants, apply Avon Care Silicone Glove regularly, and particularly before exposing your hands to any ecological stressors. The skin-softening formula reduces dryness and assists to heal currently dry and cracked hands while concurrently working to prevent additional damage with a light lotion.
Finest for Heavy Duty Use
If your hands will be exposed to major skin tension (including perpetual cleaning) either from work or experience, purchase Gloves In A Bottle for powerful defense. The water resistant lotion forms a liquid glove that lasts 4-12 hours and will not clean off, trapping natural wetness, supplying additional hydration and protecting your skin from ecological irritants, consisting of the essential soaps sanitizers that typically dry hands.
Many Citrusy Sweet
Orange-forward with a tip of pink grapefruit and a sticking around whisper of lemon and lime, Energizing Citrus Body Lotion from A Lady’s Got ta Medspa!
Finest for Beach Bottoms
It’s difficult not to associate the fragrance of coconut with the beach, and Coconut Milk & Sandalwood Deep Moisture Hand Lotion from Soapbox will psychologically carry you to the most unique coasts. Coconut milk oil’s hydrating homes originated from its abundance of fatty acids and vitamins E and K, and the additions of shea butter, olive oil and aloe offer quadruple the hydration. Benefit: For every purchase, a bar of soap is donated to someone in requirement, and you can see where yours chose the “hope code” printed on each bottle.
Finest for Nature Nuts
Whether your choose the garden or the woods, if you enjoy to get your hands dirty with earth you’ll be nuts for the range of Spit Polish Hand Lotion scents readily available from Duluth Trading Co.
The Majority Of Severe
When the damage is done and your hands remain in severe requirement of recovery and rehydration, reach for Theraderm’s Extreme Dry Skin Treatment Longer long lasting than normal moisturizers, Extreme Dry Skin Therapy includes 20%highest-grade lanolin to form a protective oil barrier on your skin’s surface, enabling the natural lipid barrier to repair and renew, while also penetrating to the inmost layers of your skin to supply moisturizing relief.
For antioxidant defense and abundant, multi-layer moisturization from lactic acid and vitamins A, C and E, use LCA fx141 Hand and Body Replenisher from Priori. Beyond lasting hydration, the sericin in this emulsion visibly corrects your hands by smoothing wrinkles, stretch marks and rough patches with day-to-day application (once or twice per day will do it for a lot of), for a benefit appeal increase with your comforting relief.
You can discover Pleased Hands, Part 1: Soaps and Sanitizers here
You can discover Happy Hands, Part 2: Lotions here
( These particular items are not backed by Dr. Zeichner, whose involvement in this series is solely as a specialist on the basic significance of skin care. Consult your physician or skin doctor to discuss the very best practices and items for you.)